These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9809686)

  • 21. Prostate specific antigen: a useful screening test?
    Concato J
    Cancer J; 2000 Apr; 6 Suppl 2():S188-92. PubMed ID: 10803835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate-specific antigen testing to screen for prostate cancer.
    Budenholzer BR
    J Fam Pract; 1995 Sep; 41(3):270-8. PubMed ID: 7544400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.
    Lin K; Lipsitz R; Miller T; Janakiraman S;
    Ann Intern Med; 2008 Aug; 149(3):192-9. PubMed ID: 18678846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferences of elderly men for prostate-specific antigen screening and the impact of informed consent.
    Wolf AM; Schorling JB
    J Gerontol A Biol Sci Med Sci; 1998 May; 53(3):M195-200. PubMed ID: 9597051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prostate cancer screening].
    Villers A; Rébillard X; Soulié M; Davin JL; Coloby P; Moreau JL; Mejean A; Irani J; Coulange C; Mangin P;
    Prog Urol; 2003 Apr; 13(2):209-14. PubMed ID: 12765053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer. When to offer screening in the primary care setting.
    Gambert SR
    Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of interest in prostate-specific antigen screening and the impact of informed consent: what should we tell our patients?
    Wolf AM; Philbrick JT; Schorling JB
    Am J Med; 1997 Oct; 103(4):308-14. PubMed ID: 9382123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Informed consent for PSA screening: does it happen?
    Federman DG; Goyal S; Kamina A; Peduzzi P; Concato J
    Eff Clin Pract; 1999; 2(4):152-7. PubMed ID: 10539539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
    Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
    Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public knowledge of benefits of breast and prostate cancer screening in Europe.
    Gigerenzer G; Mata J; Frank R
    J Natl Cancer Inst; 2009 Sep; 101(17):1216-20. PubMed ID: 19671770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial panel on informed consent for PSA screening.
    Ramsden AR; Chodak G
    Urology; 2003 Sep; 62(3):589. PubMed ID: 12946782
    [No Abstract]   [Full Text] [Related]  

  • 36. PSA screening: a public health dilemma.
    Mandelson MT; Wagner EH; Thompson RS
    Annu Rev Public Health; 1995; 16():283-306. PubMed ID: 7543756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uninformed consent: mass screening for prostate cancer.
    Justman S
    Bioethics; 2012 Mar; 26(3):143-8. PubMed ID: 20497167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urologists' personal feelings on PSA screening and prostate cancer treatment.
    Wenzler DL; Rosenberg BH
    J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.